Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the effect of melatonin on COVID-19
IRCT20210411050925N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in coronavirus disease 2019 (COVID-19), sponsored by Iran University of Medical Sciences. Started Feb 2022; status: completed.
02
Drugs
melatonin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210411050925N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210411050925N1.